Tocilizumab in patients infected by SARS-CoV2
| UDC.coleccion | Investigación | es_ES |
| UDC.departamento | Ciencias da Saúde | es_ES |
| UDC.endPage | 406 | es_ES |
| UDC.grupoInv | Grupo de Investigación Cardiovascular (GRINCAR) | es_ES |
| UDC.issue | 8 | es_ES |
| UDC.journalTitle | Medicina Clínica (English Edition) | es_ES |
| UDC.startPage | 402 | es_ES |
| UDC.volume | 156 | es_ES |
| dc.contributor.author | Sancho, Milagros | |
| dc.contributor.author | Muñiz, Javier | |
| dc.contributor.author | Cardinal-Fernández, Pablo | |
| dc.date.accessioned | 2022-03-07T13:16:33Z | |
| dc.date.embargoEndDate | 2022-03-19 | es_ES |
| dc.date.embargoLift | 2022-03-19 | |
| dc.date.issued | 2021-03-19 | |
| dc.identifier.citation | Sancho M, Muñiz J, Cardinal-Fernández P. Tocilizumab in patients infected by SARS-CoV2. Med Clin (Eng Ed). 2021;156(8):402-406 | es_ES |
| dc.identifier.issn | 2387-0206 | |
| dc.identifier.uri | http://hdl.handle.net/2183/29890 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.relation.uri | https://doi.org/10.1016/j.medcle.2020.12.010 | es_ES |
| dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International Licence (CC-BY-NC-ND 4.0) | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Tocilizumab in patients infected by SARS-CoV2 | es_ES |
| dc.title.alternative | Tocilizumab en el paciente con COVID-19 | es_ES |
| dc.type | journal article | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 374da306-27ea-473b-8398-799188417bc4 | |
| relation.isAuthorOfPublication.latestForDiscovery | 374da306-27ea-473b-8398-799188417bc4 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Sancho_Tocilizumab.pdf
- Size:
- 182.63 KB
- Format:
- Adobe Portable Document Format
- Description:

